Literature DB >> 2528507

Comparison of T-cell responses in self-limiting versus progressive visceral Leishmania donovani infections in golden hamsters.

C Gifawesen1, J P Farrell.   

Abstract

Leishmania donovani infection in golden hamsters was studied as a model for human kala-azar. After intradermal inoculation of L. donovani amastigotes, hamsters developed positive skin reactions (delayed-type hypersensitivity [DTH]) to parasite antigens and lymphoid cells from these hamsters proliferated to parasite antigens in vitro and transferred DTH reactivity to normal recipients. In contrast, hamsters infected by the intracardial route developed progressive visceral infections and failed to respond to skin test antigens. Spleen cells, lymph node cells, and peripheral blood lymphocytes (PBLs) from these hamsters were unresponsive to parasite antigens in vitro, and spleen cells failed to transfer DTH to normal recipients. Spleen cells, but not PBLs, displayed depressed responses to T-cell mitogens and also suppressed the proliferative response of cells from hamsters inoculated intradermally. Removal of adherent cells restored the capacity of spleen cells, but not PBLs, to respond to parasite antigens. The nonadherent population of these spleen cells also transferred DTH to normal recipients. The adherent suppressor cells, which have the characteristics of macrophages, appear to be localized to the spleen and are apparently not responsible for the failure of peripheral lymphoid cells to respond to antigen. These studies suggest that hamsters with visceral infections develop a population of antigen-reactive cells and that in the absence of suppression these cells may express functional activities, including the capacity to elicit DTH responses.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2528507      PMCID: PMC260774          DOI: 10.1128/iai.57.10.3091-3096.1989

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  30 in total

1.  Immunity in kala-azar.

Authors:  P E MANSON-BAHR
Journal:  Trans R Soc Trop Med Hyg       Date:  1961-11       Impact factor: 2.184

2.  Leishmania donovani: acquired resistance to visceral leishmaniasis in the golden hamster.

Authors:  J P Farrell
Journal:  Exp Parasitol       Date:  1976-08       Impact factor: 2.011

3.  Phytohaemagglutinin-induced lymphocyte transformation test in Indian kala-azar.

Authors:  A C Ghose; J P Haldar; S C Pal; B P Mishra; K K Mishra
Journal:  Trans R Soc Trop Med Hyg       Date:  1979       Impact factor: 2.184

4.  Peritoneal exudate T lymphocytes with specificity to sheep red blood cells. II. Inflammatory helper T cells and effector T cells in mice with delayed-type hypersensitivity and in suppressed mice.

Authors:  H Hahn; S H Kaufmann; F Falkenberg; M Chahinin; W Horn
Journal:  Immunology       Date:  1979-09       Impact factor: 7.397

5.  "Panning" for lymphocytes: a method for cell selection.

Authors:  L J Wysocki; V L Sato
Journal:  Proc Natl Acad Sci U S A       Date:  1978-06       Impact factor: 11.205

6.  Antigen-induced selective recruitment of circulating lymphocytes.

Authors:  J Sprent; J F Miller; G F Mitchell
Journal:  Cell Immunol       Date:  1971-04       Impact factor: 4.868

7.  Proliferative glomerulonephritis in experimental Leishmania donovani infection of the golden hamster.

Authors:  W E Agu; J P Farrell; E J Soulsby
Journal:  Comp Immunol Microbiol Infect Dis       Date:  1981       Impact factor: 2.268

8.  Characterization of strains of Leishmania donovani.

Authors:  L A Stauber
Journal:  Exp Parasitol       Date:  1966-02       Impact factor: 2.011

9.  Cell-mediated immunity in American visceral leishmaniasis: reversible immunosuppression during acute infection.

Authors:  E M Carvalho; R S Teixeira; W D Johnson
Journal:  Infect Immun       Date:  1981-08       Impact factor: 3.441

10.  Experimental cutaneous leishmaniasis. I. Nonspecific immunodepression in BALB/c mice infected with Leishmania tropica.

Authors:  P A Scott; J P Farrell
Journal:  J Immunol       Date:  1981-12       Impact factor: 5.422

View more
  24 in total

1.  Setting new immunobiological parameters in the hamster model of visceral leishmaniasis for in vivo testing of antileishmanial compounds.

Authors:  M A Dea-Ayuela; S Rama-Iñiguez; J M Alunda; F Bolás-Fernandez
Journal:  Vet Res Commun       Date:  2007-01-19       Impact factor: 2.459

2.  Photodynamic vaccination of hamsters with inducible suicidal mutants of Leishmania amazonensis elicits immunity against visceral leishmaniasis.

Authors:  Shraddha Kumari; Mukesh Samant; Prashant Khare; Pragya Misra; Sujoy Dutta; Bala Krishna Kolli; Sharad Sharma; Kwang Poo Chang; Anuradha Dube
Journal:  Eur J Immunol       Date:  2009-01       Impact factor: 5.532

3.  Cloning of Syrian hamster (Mesocricetus auratus) cytokine cDNAs and analysis of cytokine mRNA expression in experimental visceral leishmaniasis.

Authors:  P C Melby; V V Tryon; B Chandrasekar; G L Freeman
Journal:  Infect Immun       Date:  1998-05       Impact factor: 3.441

Review 4.  Immunopathogenesis of non-healing American cutaneous leishmaniasis and progressive visceral leishmaniasis.

Authors:  Lynn Soong; Calvin A Henard; Peter C Melby
Journal:  Semin Immunopathol       Date:  2012-10-11       Impact factor: 9.623

5.  Real-time reverse transcription-PCR quantification of cytokine mRNA expression in golden Syrian hamster infected with Leishmania infantum and treated with a new amphotericin B formulation.

Authors:  S Rama Iñiguez; M A Dea-Ayuela; J A Sanchez-Brunete; J J Torrado; J M Alunda; F Bolas-Fernández
Journal:  Antimicrob Agents Chemother       Date:  2006-04       Impact factor: 5.191

6.  Cyclophosphamide affects the dynamics of granuloma formation in experimental visceral leishmaniasis.

Authors:  E B Corrêa; J M Cunha; M M Bunn-Moreno; E D Madeira
Journal:  Parasitol Res       Date:  1992       Impact factor: 2.289

7.  Combination therapy with paromomycin-associated stearylamine-bearing liposomes cures experimental visceral leishmaniasis through Th1-biased immunomodulation.

Authors:  Antara Banerjee; Manjarika De; Nahid Ali
Journal:  Antimicrob Agents Chemother       Date:  2011-01-10       Impact factor: 5.191

8.  Immunosuppression in hamsters with progressive visceral leishmaniasis is associated with an impairment of protein kinase C activity in their lymphocytes that can be partially reversed by okadaic acid or anti-transforming growth factor beta antibody.

Authors:  Ananda Mookerjee; Parimal C Sen; Asoke C Ghose
Journal:  Infect Immun       Date:  2003-05       Impact factor: 3.441

9.  Immunoadjuvant chemotherapy of visceral leishmaniasis in hamsters using amphotericin B-encapsulated nanoemulsion template-based chitosan nanocapsules.

Authors:  Shalini Asthana; Anil K Jaiswal; Pramod K Gupta; Vivek K Pawar; Anuradha Dube; Manish K Chourasia
Journal:  Antimicrob Agents Chemother       Date:  2013-01-28       Impact factor: 5.191

Review 10.  Visceral leishmaniasis treatment: What do we have, what do we need and how to deliver it?

Authors:  Lucio H Freitas-Junior; Eric Chatelain; Helena Andrade Kim; Jair L Siqueira-Neto
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2012-01-28       Impact factor: 4.077

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.